Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06731647

Non-steroidal Anti-inflammatory Drugs in Pleurodesis Surgery for Pneumothorax

Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-03-19

358

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire, Amiens

Lead Sponsor

C

Centre Hospitalier VALENCIENNES

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the safety and pain management effects of non-steroidal anti-inflammatory drugs (NSAIDs) during pleurodesis surgery for pneumothorax. There is debate about using NSAIDs in this surgery because they might interfere with the pleurodesis process and increase the risk of pneumothorax coming back. The investigators believe NSAIDs can be safe and improve pain control without raising this risk. Participants will either receive ketoprofen, an NSAID, with one intravenous dose followed by five oral doses every 12 hours for 72 hours, or a placebo with a similar schedule. All patients will undergo pleurodesis surgery under general anesthesia with pain management options allowed at the doctor's discretion. The study uses a double-blind, randomized design to compare these treatments. During the hospital stay, pain will be assessed every 12 hours using a pain scale. Researchers will monitor the duration of pleural drainage and track postoperative pain, opioid use, pneumonia occurrence, hospital stay length, and pneumothorax recurrence at multiple time points up to one year. Neuropathic pain will also be screened at 48 hours, 1 month, 6 months, and 1 year after treatment. The study participation may last up to 6 months or longer depending on follow-up.

CONDITIONS

Brief Title

Non-steroidal Anti-inflammatory Drugs in Pleurodesis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosis of pneumothorax with indication for pleurodesis
  • Surgery performed via thoracotomy or thoracoscopy
  • Patients with or without minimal lung resection
Not Eligible

You will not qualify if you...

  • Under 18 years old (minor patient)
  • Pregnant, parturient, or breastfeeding patients
  • Severe polytrauma with Vittel criteria
  • Presence of purulent pleurisy
  • Hemopneumothorax
  • Lactose hypersensitivity
  • Contraindications to NSAIDs
  • Contraindications to tramadol
  • Contraindications to paracetamol
  • Receiving curative anticoagulation
  • Under guardianship or deprived of liberty
  • Patient refusal

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit

Surgery and Immediate Post-operative Care

Duration - Up to hospital discharge (duration varies per participant)

Participants undergo pleurodesis surgery under general anesthesia with various pain management strategies. After surgery, pleural fluid or air is monitored with a chest tube connected to a drainage device. Pain is assessed every 12 hours during the hospital stay.

Daily in-hospital monitoring visits

Treatment

Duration - 72 hours

Participants receive either ketoprofen or placebo: one intravenous dose followed by 5 doses every 12 hours over 72 hours.

Dosing every 12 hours for a total of 6 doses

Post-operative Follow-up

Duration - Up to 12 months

Participants are monitored for postoperative pain, opioid use, pneumonia occurrence, length of hospital stay, and recurrence of pneumothorax at 1 month, 6 months, and 12 months after surgery.

Pain and neuropathic pain assessments at 48 hours, 1 month, 6 months, and 12 months; additional follow-up visits as needed

Trial Site Locations

Total: 1 location

1

Centre Hospitalier Universitaire d'Amiens

Amiens, France, 80054

Actively Recruiting

Loading map...

Research Team

F

Florent LEVIEL, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Acute Effects of Transcutaneous Electrical Nerve Stimulation...

Pain Management

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here